U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1998
123
Substance Class Structurally Diverse
Created
by admin
on Mon Mar 31 21:29:12 GMT 2025
Edited
by admin
on Mon Mar 31 21:29:12 GMT 2025
Source Materials Class ORGANISM
Source Materials Type MAMMAL
Source Materials Parent
ORYCTOLAGUS CUNICULUS WHOLE
Part blood serum
Fraction Name sera immunoglobulin igg
Record UNII
D7RD81HE4W
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN
Common Name English
ANTITHYMOCYTE IMMUNOGLOBULIN
WHO-DD  
Preferred Name English
ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN, RABBIT [JAN]
Common Name English
RABBIT ANTI-HUMAN THYMOCYTE GLOBULIN
Common Name English
ATG FRESENIUS
Brand Name English
ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT)
Common Name English
ANTI-T-LYMPHOCYTE IMMUNE GLOBULIN, RABBIT
Common Name English
RABBIT ANTI-HUMAN THYMOCYTE GLOBULIN (RATG)
Common Name English
Antithymocyte immunoglobulin (rabbit) [WHO-DD]
Common Name English
EZ-2053
Code English
RABBIT ANTI-HUMAN THYMOCYTE IMMUNOGLOBULIN
Systematic Name English
RABBIT ANTITHYMOCYTE GLOBULIN
Common Name English
ANTI-THYMOCYTE GLOBULIN (RABBIT)
Common Name English
Antilymphocyte immunoglobulin (rabbit) [WHO-DD]
Common Name English
ANTI-THYMOCYTE GLOBULIN RABBIT
Common Name English
RABBIT ATG
Common Name English
TECELAC
Brand Name English
Antithymocyte immunoglobulin [WHO-DD]
Common Name English
RABBIT ANTI-THYMOCYTE IMMUNOGLOBULIN
Common Name English
ANTI-HUMAN THYMOCYTE IMMUNOGLOBULIN, RABBIT [JAN]
Common Name English
ANTI-HUMAN THYMOCYTE IMMUNOGLOBULIN, RABBIT
JAN  
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 308710
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
NDF-RT N0000184163
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
FDA ORPHAN DRUG 182503
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
FDA ORPHAN DRUG 136800
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
WHO-VATC QL04AA04
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
FDA ORPHAN DRUG 64491
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
FDA ORPHAN DRUG 301810
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
FDA ORPHAN DRUG 226006
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
FDA ORPHAN DRUG 838821
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
NCI_THESAURUS C2701
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
WHO-ATC L04AA04
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
Code System Code Type Description
NCI_THESAURUS
C80833
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
PRIMARY
EVMPD
SUB128808
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
PRIMARY
DRUG BANK
DB00098
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
PRIMARY
SMS_ID
100000090074
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
PRIMARY
NDF-RT
N0000178327
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
PRIMARY Lymphocyte Function Alteration [PE]
CAS
308067-60-9
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
GENERIC (FAMILY)
FDA UNII
D7RD81HE4W
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
PRIMARY
NDF-RT
N0000009689
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
PRIMARY Increased T Lymphocyte Destruction [PE]
NDF-RT
N0000007920
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
PRIMARY Immunoglobulins [Chemical/Ingredient]
NDF-RT
N0000020023
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
PRIMARY Antibody-Surface Protein Interactions [MoA]
DAILYMED
D7RD81HE4W
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
PRIMARY
MESH
C512542
Created by admin on Mon Mar 31 21:29:12 GMT 2025 , Edited by admin on Mon Mar 31 21:29:12 GMT 2025
PRIMARY
Related Record Type Details
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN
ACTIVE MOIETY

Agent Modifications

Modification Process Modification Role Modification Type Amount Fragment Name Fragment ID
TARGETED ANTIGEN IMMUNOLOGICAL HUMAN THYMOCYTE, AUTOLOGOUS J56RKY13OV
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966